Launch of telemedicine in community oncology practice.

Authors

L. Johnetta Blakely

L. Johnetta Blakely

Tennessee Oncology, Nashville, TN

L. Johnetta Blakely, Natalie R. Dickson, Jack William Erter, Carolyn Craig, Holly Bushart, David Stewart, Mary Darden, Ann Ripley, Stacey L Poole, Susan Frailey, Jeffrey Patton

Organizations

Tennessee Oncology, Nashville, TN, Tennessee Onc PLLC, Nashville, TN, Tennessee Oncology PLLC, Nashville, TN, Tennessee Oncology, PLLC/SCRI, Nashville, TN

Research Funding

No funding received
None.

Background: Tennessee Oncology (TO) is a community medical, radiation and gynecology oncology practice with 90 physicians and 40 advanced practice providers (APPs) in 33 locations in Tennessee. TO participates in the Oncology Care Model (OCM), a CMMI experimental payment model to improve access, quality of care, patient experience and lower costs. Methods: To promote provider-patient communication to improve outcomes and lower healthcare costs, TO launched a telemedicine pilot. The pilot was designed to understand Tennessee’s rules and regulations, reimbursement policies for Medicare, Medicaid and commercial payers and technology requirements. As survivorship was aligned with clinical workflow, supported by existing technology and required minimal staff training, the Survivorship Program for OCM was selected as proof of concept for telemedicine. Education surrounding Survivorship is required as part of the OCM model. A portion of the MEOS payment was considered as reimbursement for this initiative. The goal was to increase the delivery and review of survivorship documents to eligible breast cancer patients using the telemedicine platform from 0% to 80%. Results: 4000 potential patients were eligible for survivorship visits within TO. The selection was narrowed to include only OCM patients with breast cancer. TO identified 4 APPs who were given special training. TO’s front office staff coordinated scheduling of the technology, provider and space available. There were 99 patients eligible for a Telemedicine visit. 36 patients completed a Telemedicine visit with 23 patients declining. 19 patients did not respond to requests for these visits. 10 patients completed surveys and were 100% satisfied with their visits. The APPs felt Telemedicine visits were more productive than in person visits. Conclusions: Telemedicine is an effective tool for delivery of health care. There are challenges that make this technology difficult to implement such as reimbursement and limitations to the use of technology in elderly. In our pilot we found that the APPs and patients found this to be an effective way of communication and delivery of care. In the future telemedicine could answer some of the shortages in health care delivery and could also improve coordination of care.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2019 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session B: Patient Experience; Safety; Technology and Innovation in Quality of Care

Track

Patient Experience,Technology and Innovation in Quality of Care,Safety

Sub Track

Impact of Telemedicine

Citation

J Clin Oncol 37, 2019 (suppl 27; abstr 275)

DOI

10.1200/JCO.2019.37.27_suppl.275

Abstract #

275

Poster Bd #

H4

Abstract Disclosures

Similar Abstracts

First Author: Youmin Cho

First Author: Kathryn E. Weaver

Abstract

2023 ASCO Quality Care Symposium

Loss to primary care provider follow-up among survivors five to seven years post-diagnosis.

First Author: Alexandra G. Peluso

Abstract

2023 ASCO Annual Meeting

Value-driven colorectal cancer survivorship through partnership with primary care.

First Author: Gloria Hui Jia Chan